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a  b  s  t  r  a  c  t
The  balance  between  reactive  oxygen  species  and  reactive  nitrogen  species  production  by  the  host  and
stress  response  by  fungi  is a key  axis  of  the  host-pathogen  interaction.  This review  will  describe  emerging
themes  in  fungal  pathogenesis  underpinning  this  axis.
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Fig. 1. Schematic representation of the formation of reactive oxygen species (ROS)
and  reactive nitrogen species (RNS) in the human host. Oxygen is reduced by the
NADPH oxidase in phagocytes (NOX2) or in epithelial cells (DUOX) or by the mito-
chondria. The superoxide (O2•) generated is converted by superoxide dismutase
(SOD) into hydrogen peroxide (H2O2). H2O2 is either converted by myeloperoxidase
(MPO) into hypochlorite (HOCl), or into water (H2O) and oxygen, or into hydroxyl
radicals (OH−•) in the Fenton reaction catalysed by iron. The production of nitric
oxide (NO−•) requires L-arginine to be converted to L-citrulline driven by inducibleReferences  . . .  . . .  . .  . . . . .  . . . . . . .  . . .  . . .  .  . . .  .  . . .  . . . . . . . . . . . . . . .  . . .  . .  . .  .  . . .
. Introduction
Reactive Oxygen and Reactive Nitrogen Species (ROS/RNS) arise
s bi-products of cellular function and through the regulated
ctivity of ROS/RNS-generating enzymes. In the host, mitochon-
rial ROS serve as markers of metabolic activity, apoptosis, and
yroptosis [1–3]. Phagocytosis and cytokine stimulation activate
ost NADPH Oxidase (NOX, ROS burst) and Nitric Oxide Syn-
hase (NOS, NO−), both of which serve to neutralise invading
athogens. The signiﬁcance of the host oxidative response in the
esistance to invasive fungal disease is highlighted by the sus-
eptibility of patients deﬁcient in this response [4]. In response
o host oxidative and nitrositive stress, pathogenic fungi engage
ranscriptional, post-translation, and enzymatic (Superoxide Dis-
utase (SOD), catalase, thioreductase, glutathione) responses as
art of oxidative stress responses that enable resistance to ROS/RNS
oxicity and facilitate adaptation to the host. A number of recent
eviews have examined our understanding of transcriptional and
ost-translational responses [5,6], however emerging data sug-
est a complex interplay between enzymatic ROS detoxiﬁcation,
itochondrial function, and host pathogenicity. For example, fungi
eﬁcient in SOD exhibit reduced pathogenicity: Candida albi-
ans, Cryptococcus neoformans, and Aspergillus fumigatus SODs are
equired for full virulence, and defects in oxidative stress response
athways attenuate fungal resistance to phagocyte killing [7–10].
owever, there is signiﬁcant redundancy, and in most cases, loss of
 single detoxiﬁcation strategy has a limited impact on overall vir-
lence [7–10]. Additionally, fungi encode an orthologous NADPH
xidase complex with an underappreciated inﬂuence on fungal
nfection biology and pathogenesis in the host [11–14]. Therefore,
e take this opportunity to ﬁll a gap in the literature by examining
OS/RNS generation by the host and fungus during fungal infec-
ion, focusing on the role of these two emerging aspects of infection
iology in the fungal oxidative stress response.
. Basic biology
.1. The host
In the host, ROS/RNS production increases upon exposure to
oxins and stimulation of host NADPH oxidase and iNOS pathways
y micro-organisms. Polymorphonuclear and mononuclear phago-
ytes express both NADPH oxidase and iNOS. Neutrophils produce
he vast majority of ROS, while macrophages generally produce
onsiderably more RNS [15]. Target microbes then accumulate cell
njury as a result of oxidative stress, causing DNA mutations that
ead to changes in gene expression, as well as post-translational
rotein modiﬁcation and lipid peroxidation.
Phagocyte-derived reactive oxygen and nitrogen intermediates
ROI and RNI) are of crucial importance for host resistance to micro-
ial pathogens (Fig. 1). Their potent antimicrobial activity can be
xplained by their rapid and high production, a small molecular
ize and transmembrane diffusibility [16]. Superoxide (O2−•) is
enerated by the NADPH phagocyte oxidase (phox) [17]. Superox-
de alone is generally considered to be poorly toxic to microbes,
lthough the amounts generated intraphagosomally are consid-
red to be microbicidal [18]. However, superoxide generation leads
o the accumulation of ROIs including hydrogen peroxide (H2O2),
ydroxyl anion (HO−) and hypochlorous acid (HOCl). Superoxidenitric oxide synthase (iNOS) in the presence of oxygen. Subsequent spontaneous
reactions involving O2• and NO−• can result in the formation of nitrogen dioxide
(NO2•) and peroxynitrite (ONOO−•).
anions are unstable and will convert either spontaneously or via
superoxide dismutase (SOD) to H2O2. In neutrophils, myeloperox-
idase (MPO) converts H2O2 to the highly microbicidal HOCl, and
MPO  is required for antifungal defense [19]. MPO  also participates
in the IFN mediated priming of phagocytes for phox-dependent
ROI production [20].
Nitric oxide radicals, including NO−• and its derivatives (Reac-
tive Nitrogen Intermediates, RNIs) arise via the inducible nitric
oxide synthase (iNOS) pathway. The production of NO− requires
the amino acid l-arginine to be converted to NO− and citrulline
driven by iNOS activity in the presence of oxygen [21]. NADPH
oxidase and MPO  are constitutively expressed, while iNOS is not
[16]. ROIs and RNIs react with each other as well, resulting in the
generation of peroxynitrite [22]. The complex inter-relationships
between ROS and RNS becomes manifest in MPO  KO mice, where
the augmented expression of iNOS and NO− production results in
less sepsis-induced lung injury and death [23].
In addition to the NADPH oxidases, two  dual-speciﬁc oxidases
(DUOX1/2) produce H2O2 rather than superoxide and are found
predominantly in epithelial cells [24,25]. DUOX has been impli-
cated in mucosal antimicrobial defence and the recruitment of
leukocytes to the infected tissue [26]. Other ROS generating path-
ways are the electron transport chain in mitochondria [27], the
xanthine oxidase system [28], monooxygenases and oxidases in
peroxisomes, and the pseudoperoxidase or phenoloxidase activity
of hemoglobulin or hemocyanin respectively[22].
2.1.1. NADPH phagocyte oxidase
Although the respiratory burst was  characterized in the early
20th century, it took another 60 years to unravel the molecular
mechanisms underlying this phenomenon and to demonstrate that
NAPDH oxidase is the primary enzyme for generating this oxida-
tive burst [29–32]. Five different isoforms of NADPH-dependent
oxidases (NOX1-5) are known, of which NOX2 plays the most sig-
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iﬁcant role in antimicrobial and regulatory pathways (discussed
urther below) [28]. The NADPH oxidase in phagocytes (NOX2)
onsists of two membrane bound proteins, gp91phox and p22phox
together the cytochrome b), and four cytosolic proteins, p47phox,
67phox, p40phox and Rac [33]. Segal et al. were the ﬁrst to show
hat cytochrome b is responsible for the production of ROS [34].
owadays, mutations in the X-linked inherited CYBB and the auto-
omal recessive CYBA, NCF1, NCF2 and NCF4 are known, and result
n chronic granulomatous disease due to a defective function of the
ADPH oxidase [35].
Activation of the NADPH phagocyte oxidase occurs in response
o a variety of physiological stimuli, including opsonized particles
nd ligation of speciﬁc pathogen recognition receptors including
ectin-1 [41,42]. In vitro, ROS can be stimulated by chemicals such
s phorbol myristate acetate (PMA) through phosphorylation of
47-phox and activation of Nox2 [36,37].
The clinical signiﬁcance of the NADPH phagocyte oxidase is well
ecognized as defects in the genes encoding this enzyme result
n chronic granulomatous disease (CGD), one of the most sig-
iﬁcant aspergillosis patient populations [38]. CGD patients have
he highest life-time incidence of invasive aspergillosis, and birth
revalence ranges from 1/250,000 to 1/120,000 in European coun-
ries and the US [16–19].
In addition to the direct antimicrobial effect of ROS, reactive oxy-
en molecules also play an important role in inﬂammation control,
ost-tissue injury, and numerous intracellular signalling path-
ays [39,40], releasing and activating cationic granule proteins
cathepsin G, elastase), autophagy and extracellular trap formation
41–44]. Key intracellular events to which ROS are linked include
he activation of transcription factors including NFB [45], induc-
ion of mitogenesis [46], and acting as substrate or cofactor for the
nzymatic activity of indoleamine 2,3-dioxygenase (IDO) [47–49].
ctivation of NADPH oxidase is coupled to the release of preformed
ntimicrobial proteases in the neutrophil that effectively prevent
ermination and display fungicidal activity [50]. The activation of
ADPH oxidase leads to a rise in ionic strength necessary to release
nd activate cationic granule proteins [51]. In the CGD host, it is
nclear to what extent the impaired activation of neutrophil pro-
eases plays a role in susceptibility to invasive fungal infection, in
ddition to the absence of ROS. Normalisation of the phagolyso-
omal pH in CGD phagocytes increases the microbicidal activity
f neutrophils [51]. In support of this, chloroquine (acidotrophic
gent) increased the antifungal activity of neutrophils from CGD
atients against A. fumigatus and A. nidulans [52].
Rac2 is a small Rho GTPase which is required for normal neu-
rophil function and is part of the NADPH oxidase complex. Patients
ith the Rac2D57N mutation have impaired neutrophil chemotaxis
nd superoxide production, resulting in severe recurrent bacterial
nfections [53,54]. As yet, no fungal infections have been described
n patients with Rac2-deﬁciency.
.1.2. Inducible nitric oxide synthase
Although NO−• production has been studied most extensively in
acrophages, a subset of dendritic cells and non-phagocytic cells
lso use NO−• to kill microorganisms. The activity of iNOS is mainly
egulated at the transcriptional level and is stimulated by micro-
ial pathogen recognition receptors together with signalling from
roinﬂammatory cytokines (IFNs, IL-1, TNF) [55]. As RNS pro-
uction requires de novo protein synthesis, this response is less
mmediate than that observed for ROS production [55].
NO−• regulates leukocyte recruitment and attachment through
uppression of adhesion molecule activity, e.g. CD11/CD18 [56].
O− is consumed by neutrophils in a partly SOD dependent man-
er, but also other neutrophilic oxidases (including MPO) can
atalytically consume NO− in vitro [57,58]. Clark et al. [59] showed
hat CGD neutrophils, in contrast to MPO-deﬁcient and healthyvelopmental Biology 89 (2019) 34–46
neutrophils, are unable to metabolize NO−•. On the other hand,
Condino-Neto et al. [60] showed that O2−• production is not essen-
tial for NO−• synthesis in neutrophils and mononuclear phagocytes,
as they showed NO−• production by CGD phagocytes indirectly by
inhibition of thrombin-induced washed platelet aggregation [60].
Although several iNOS promoter polymorphisms have been
linked to increased iNOS expression playing a role in malaria
pathology [61,62], no associations have been reported with fungal
infections. iNOS deﬁciency in humans has not been demonstrated
[61,62].
2.1.3. Myeloperoxidase
Myeloperoxidase (comprising 5% of the total protein in neu-
trophils) generates hyperchlorous acid (HOCl) through oxidation of
chloride with H2O2 [38,63]. Myeloperoxidase deﬁciency in humans
is common (1/2,000–1/4,000 in Europe and North-America) but
usually asymptomatic [64]. An increased susceptibility to Candida
infections may  be observed (<5%), but often only develop if other
predisposing conditions are present [64]. Aspergillus infections in
humans with MPO  deﬁciency have not been described, although
MPO-deﬁcient mice are more susceptible to aspergillus infection
[19]. In addition, a role for MPO  in the inﬂammatory response has
been suggested. Myeloperoxidase-derived HOCl leads to oxidative
degradation of foreign particles and an attenuation of the inﬂam-
matory response [65].
2.2. The fungus
2.2.1. Mitochondrial ROS
Within the fungus, the mitochondrion is the major source of
ROS (Fig. 2). Classically, ROS are considered to be damaging agents
generated in the cell as the necessary bi-products of cellular activ-
ity [66]. In the mitochondrion, oxidative phosphorylation enables
the build-up of a proton gradient across the mitochondrial inner
membrane, culminating in the conversion of ADP to ATP [67]. ROS
accumulate as a direct consequence of oxidative phosphorylation
and must be rapidly converted by cytoplasmic and mitochon-
drial SOD to hydrogen peroxide (H2O2), which is more stable than
superoxide but can diffuse across membranes, targeting DNA  [66].
Further detoxiﬁcation of H2O2 is mediated by catalase (within
peroxisomes and mitochondria), glutathione peroxidase, peroxire-
doxins, and thioredoxins [68–71].
Mitochondrial Complex I and III are the major sources of O2−
in the mitochondrion [72]. While establishing a proton gradi-
ent across the inner mitochondrial membrane, O2− produced by
Complex I (NADH:ubiquinone oxidoreductase) accumulates within
the mitochondrial matrix [73–76]. In contrast, O2− from Com-
plex III accumulates primarily in the intermembrane space [77].
The distinct localisation demands distinct pools of SOD: Cu/Zn-Sod
localised to the matrix, and Mn-Sod localised to the intermem-
brane space [66]. Complex IV also accepts electrons from Complex
III, converting molecular oxygen to H2O, thereby contributing to
detoxiﬁcation [78]. H2O2 must be further detoxiﬁed by catalase
and glutathione. The Haber-Weiss reaction and Fenton chemistry
convert O2− and H2O2 to highly reactive hydroxide radicals (HO−),
and oxidative stress in particular can cause the accumulation of
hydroxyl anion HO− in mitochondria [79].
2.2.2. Electron transfer in fungi
During phagocytosis, fungal Complex IV is inhibited by NO−,
a major product of iNOS-expressing macrophages [80,81]. This
leads to the accumulation of Complex III-derived O2−. Most fungi
encode an Alternative Oxidase (AOX) that bypasses Complex III and
IV, allowing them to cope with accumulating superoxide [82–85].
For example, loss of Aox1 in C. neoformans increases killing by
phagocytes [84]. Fungi additionally encode Type II NAD(P)H dehy-
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Fig. 2. In the absence of exogenous stress (normal growth, purple), oxidative phosphorylation enables the build-up of a proton gradient across the mitochondrial inner
membrane (blue lines), culminating in the conversion of ADP to ATP. Superoxide (O2−) produced by Complex I, II and III accumulates in the matrix, where it is detoxiﬁed
to  H2O2 by Mn-Sod2. Complex III also produces reactive oxygen species (ROS) in the intermembrane space, where it is converted to H2O2 by Cu/Zn-Sod1. H2O2 can cross
membranes and must be further detoxiﬁed to H2O by catalase in the mitochondrion, in the cytoplasm, and in specialised vesicles called peroxisomes. In some species,
catalase and Sod1 are also found in extracellular vesicles. During exposure to host nutritional immunity, copper, zinc, iron and manganese are limited. The metal co-factor
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eorresponding to each enzyme is indicated. In C. albicans, low copper triggers the
ranscription factor. This reduces copper requirements in the cell, enabling contin
ron-dependent Aox1. Under low iron, constitutive expression of catalase can act as
rogenases (NDE) that allows bypass of Complex I. Saccharomyces
erevisiae lacks Complex I entirely, relying on Nde1 and Nde2 for
lectron entry into the respiratory chain [86,87].
Fungal electron transport therefore constitutes a hybrid sys-
em that allows resistance to compounds that target Complex
 (rotenone) and Complex IV (NO-) [88,89]. Mitochondrial func-
ion, Aox, and Nde activity are additionally linked to fungal stress
esponse pathways. Loss of Aox in C. albicans increases sensitiv-
ty to ﬂuconazole, presumably through drug induced increases in
ntracellular ROS [90,91]. In A. fumigatus,  AoxA and Cytochrom C
CycA) cooperate to allow growth under hypoxic conditions, and
daptation to hypoxia is linked to virulence [92,93].
While NDE orthologs are present in the genomes of pathogenic
ungi, there is limited information about their role in infection.
owever, loss of C. albicans NDH51 has been shown to abrogate
lamentation [94], part of a larger emerging theme suggesting that
itochondrial ROS impacts hyphal development.
.2.3. Superoxide dismutase
Superoxide dismutases fall into three classes based on co-factor
inding and localization: Cu/Zn-Sod3 is secreted and detoxiﬁes
uperoxide in the extracellular space. Mn-Sod2 is targeted to the
itochondrial matrix, where it detoxiﬁes superoxide generated
ithin the matrix by Complex I [95,96]. Complex III generates
uperoxide within matrix and in intermembrane space (IMS),
here it is detoxiﬁed by a minor pool of Sod1 (∼3% of total Sod1)
97]. The majority of Sod1 is cytoplasmic. In S. cerevisiae,  Sod1
as recently shown to translocate to the nucleus upon ROS stress
xposure in a Mec1 kinase-dependent manner. Further, ChIP exper-ession of Mn-Sod3 and reduction of Cu/Zn-Sod1 via the Mac1 copper-responsive
omplex IV function. Superoxide detoxiﬁcation is also assisted by the activation of
k for iron in the cell.
iments demonstrated Sod1 binding to the promoters of target genes
whose regulation was  lost in a sod1 mutant, suggesting that
nuclear Sod1 has additional regulatory roles [98].
2.2.4. NADPH oxidase complex
The mammalian NADPH oxidase complex (NOX) is responsible
for the respiratory burst (Fig. 3). Fungal NOX are well described
in ﬁlamentous fungi and plant pathogens, in which a core com-
plex comprised of an NADPH Oxidase (Nox), a Nox activator (NoxR)
and Rac enable plant-fungal symbiosis and pathogenesis and fun-
gal morphogenesis [99,100]. This has important ramiﬁcations for
saprophytic Aspergillus species, where NoxA, NoxR, and Rac are
required for differentiation, apical dominance and polarised growth
[13,14,101]. Here, ROS are thought to act as signalling molecules in
the cell, reinforcing a superoxide gradient that directs polarised
growth (Fig. 3). Similarly, a C. albicans Nox complex was recently
described and was shown to inﬂuence ﬁlamentation through the
endogenous generation of a superoxide gradient outside the cell.
Candida albicans Sod5 then converts superoxide to H2O2, enhancing
polarised growth and contributing to pathogenesis [12].
2.2.5. Scavengers of reactive oxygen species
Melanin is known to be an important virulence factor by
protecting fungal cells from ROS produced by phagocytic cells
[102,103] and by modulating the host immune response [104]. Fun-
gal melanin biosynthesis via either the L-DOPA or DHN pathways
contributes to fungal oxidative and nitrositive stress resistance
[105,106]. C. neoformans L-DOPA-derived melanin mediates resis-
tance to ROS/RNS stress and also impairs phagocytosis [107,108].
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Fig. 3. The fungal NADPH oxidase complex comprises three proteins: Nox, NoxR, and Rac and has been well described in plant pathogens where it interacts with various
structural proteins to reinforce apical dominance (not shown). C. albicans Nox (Fre8) is expressed during hyphal growth and superoxide generated at the cell wall is detoxiﬁed
by  secreted anchored Sod5. This results in the built up of a H2O2 gradient. Exogenous H2O2 has been shown to cause hyperpolarisation of the bud during the C. albicans
yeast-to-hyphae transition. Exogenous H2O2 is a substrate for host MPO to generate cytotoxic HOCl, and it is detoxiﬁed by secreted fungal catalase. The human NADPH
oxidase  consists of ﬁve subunits of which 2 are localized in the plasma membrane (gp91phox and gp22phox) and three in the cytosol (gp40phox, gp47phox, gp67phox) in the
inactivated phagocyte. Upon cell activation by recognition and binding of fungal pathogens the three cytosolic subunits form a heterotrimer which translocates to the other
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enerate superoxide, and other reactive oxygen species including hydrogen peroxi
 scavenger of reactive oxygen species thereby protecting the fungal cell against kil
n Aspergillus species, loss of melanin similarly increases sensitiv-
ty to ROS and phagocyte killing, impacting both the conidial and
yphal phases [102,109]. Despite this, A. fumigatus strains deﬁcient
n melanin are not reduced for virulence in vivo [110].
. Oxidative stress responses in fungi
.1. Candida albicans
.1.1. Regulation of mitochondrial ROS during nutritional
mmunity
As mentioned above, alternate pathways for electron transport
n the fungal mitochondrion enable continued respiration in the
ace of host stress. There have been signiﬁcant advances in our
nderstanding of this ﬂexibility in the human commensal fungus
. albicans and the contribution of oxidative stress resistance to
athogenesis [6]. During dissemination, host nutrient immunity
equesters micronutrients necessary for SOD (copper, manganese,
ron), Cytochrome C (COX, Complex IV; copper), and AOX (iron)
unction [111]. C. albicans cytosolic Cu-Sod1 and Mn-Sod3 are
ifferently expressed under the control of the copper-responsive
ranscription factor Mac1, enabling adaptation to ﬂuctuating cop-
er levels in the kidney [112,113]. Cu/Zn-SOD1 levels in the cytosol
all, while Mn-Sod3 levels rise. Aox1 is activated, and there is suf-
cient copper availability for continued COX function, maintaining
itochondrial homeostasis.
A similar balance between micronutrient availability and ROSetoxiﬁcation is observed for C. albicans catalase Cat1. The con-
ersion of H2O2 to water is performed by the heme peroxidase,
atalase. C albicans Cat1, localised to the cell wall and peroxi-
omes, protects the fungus from acute oxidative and peroxideon phagocytosis of the fungal pathogen. Electrons derived from NADPH are used to
O2) and hypochlorous acid (HOCl). Melanin in the cell wall of various fungi acts as
stress, as well as combinatorial stress [10,114–116]. However, Cat1
is tightly regulated in the cell and is dispensable for virulence in
a mouse model of infection [10]. A detailed analysis of the impact
of constitutive vs.  regulated expression of Cat1 revealed that Cat1
expression depletes iron stores, and constitutive expression dis-
rupts iron homeostasis, making the fungus vulnerable in the face
of iron sequestration.
Finally, interaction with the host can alter fungal amino acid
metabolism. Upon interaction with ROS-expressing macrophages,
C. albicans speciﬁcally induces arginine biosynthesis, and this
induction is dependent on ROS and host NADPH oxidase activ-
ity [117]. Fungal arginase biosynthesis is not triggered in iNOS
expressing macrophages [117]. Instead, in macrophages expressing
iNOS, C. albicans induces host arginase, which depletes L-arginine,
the substrate for iNOS, and blocks NO− production [118]. Arginine
biosynthesis appears to support germ tube emergence and hyphal
growth by serving as a substrate for fungal arginase Car1 and urea
amidolyase Dur1/2 to produce a CO2 gradient triggering the yeast-
to-hyphal transition [119].
3.1.2. Detoxiﬁcation of exogenous ROS
Upon exposure to acute oxidative stress or co-culture with
phagocytes, C. albicans induces a transcriptional response includ-
ing catalase, glutathione peroxidase, superoxide dismutase, and
thioredoxin. However, while this response is required to survive
acute stress or survival upon phagocytosis, it appears to be dispens-
able for long-term infection [6]. Signiﬁcant effort has characterized
the role of Cap1, Hog1, and Rad53 to acute oxidative stress response
and virulence and this has been reviewed elsewhere [6]. How-
ever, together these data suggest that the ROS microenvironment
at the host-pathogen interface is dynamic and inﬂuenced by both
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ost and fungal factors. Two groups have sought to visualize inter-
ctions at this interface, in mice and zebraﬁsh models of fungal
nfection. Brothers et al. showed that fungal catalase expression is
ependent on activation of host p47phox [120]. Consistent with this,
njalbert et al. showed that CAT1 is induced upon interaction with
eutrophils, but not macrophages [121]. However, despite the clear
ctivation of CAT1 upon phagocytosis, Enjalbert et al. also report
hat only 4% of fungal cells in the kidney expressed CAT1. These
ndings may  be explained by redundancy in ROS detoxiﬁcation
trategies: C. albicans has expanded its repertoire of Sods, encoding
 class of GPI-anchored extracellular Cu-Sods (Sod4-6) [122–124].
hese Sods, which are secreted in the apo-form, lack a zinc-binding
ite, but readily bind environmental copper, activating dismutase
ctivity [124]. Sod5 is induced during the yeast-to-hyphal switch,
ampens the ROS burst during co-culture with macrophages or
eutrophils, and loss of Sod5 inhibits pathogenesis [123].
.1.3. Exogenous and endogenous ROS support hyphal growth
Several in vitro experiments have linked the fungal oxidative
tress response to the yeast-hypha transition [5,125,126]. It has
lso been reported that mild oxidative stress can enhance polar-
zed growth in a thioredoxin-regulated manner in vitro [127,128].
xposure of C. albicans yeast to an H2O2 gradient triggers hyperpo-
arisation of the new bud [127]. The physiological relevance of this
nding was recently demonstrated by the discovery that C. albi-
ans encodes a fungal NADPH Oxidase, Fre8 [12]. Fre8 and Sod5
ogether generate an H2O2 gradient outside the cell that supports
yphal growth [12].
.2. Cryptococcus species
A growing body of data suggest mitochondrial activity is
losely linked with C. neoformans infection biology. The glucoro-
ylxylomannan polysaccharide capsule is well established as an
ntioxidant defence, and capsule growth may  be inﬂuenced by
itochondrial activity [129,130]. Treatment with inhibitors of
ither canonical or alternative oxidase (Aox) at fungistatic concen-
rations prevented capsule enlargement [130]. However, capsule
nlargement is also linked to cell cycle progression [131], com-
licating efforts to separate growth defects and capsule defects.
ryptococcal mitochondria appear to be essential, as efforts to gen-
rate petite mutants similar to those that enable such studies in S.
erevisiae have failed [132].
C. neoformans var. grubii and C. gattii encode Cu/Zn-Sod1 homo-
ogues that are required for virulence and resistance to phagocytic
illing [9,133,134]. Loss of Sod1 does not impact growth, capsule,
elanin, or morphogenesis in either species, but does impacts C.
attii, but not C. neoformans var. grubbii, expression of laccase, ure-
se, and phospholipases, highlighting fundamental differences in
ow these two species respond to host stress. In both species,
n-Sod2, predicted to detoxify ROS generated by Complex III, is
equired for growth at 37 ◦C [135,136]. Interestingly, C. neofor-
ans Aox1 transcription increases at 37 ◦C. C. neoformans Aox1
s dispensable for growth, but required for full virulence [84].
ogether, these ﬁndings suggest that, unlike copper-regulated C.
lbicans Aox1, C. neoformans Aox1 is not able to compensate for
he accumulation of Complex III-derived superoxide in the host. In
ontrast to C. albicans, which has expanded its repertoire of SOD,
ut encodes a single catalase, C. neoformans and C. gattii encode
xpanded catalase families (CnCat1-4, CgCat1-3). However, a C.
eoformans quadruple catalase mutant showed no defects in stress
esistance, growth, or pathogenicity [137]. Sod3 has not been char-
cterised in either species, although both genomes encode a single
redicted Fe/Mn-Sod protein. Proteomic analysis has identiﬁed C.
eoformans Cu/Zn-Sod and catalase within extracellular vesicles,velopmental Biology 89 (2019) 34–46 39
suggesting they may  have unidentiﬁed roles in detoxiﬁcation of
environmental ROS [138,139].
Mitochondrial morphology contributes to virulence in C. gat-
tii outbreak strains [140]: virulent strains exhibit mitochondrial
fusion upon phagocytosis by host cells, and this is linked to
increased intracellular proliferation rate [132]. Microarray analysis
found increased expression of mitochondrial genes. Further work
demonstrated that tubularisation is triggered in a sub-population
of cells by exposure to host ROS, and that tubularised cells are qui-
escent yet inﬂuence proliferation rate in their neighbors [141]. The
molecular mechanisms underpinning this division of labor remain
uncharacterised. Similar tubularisation has not been observed in C.
neoformans var. grubbii.
3.3. Aspergillus species
Aspergillus fumigatus encodes 4 Sods – Cu/ZnSod1 and Mn-Sod2-
4 [142]. All four are intracellular, but patients with Aspergillosis
are seropositive for Sod1 [143–146], and anti-Sod3 IgE is associ-
ated with allergic response [147,148]. Consistent with their role in
detoxifying mitochondrial ROS, Sod1 and Sod2 are highly expressed
during conidial germination, when spores convert from a metabol-
ically inactive to active state, and loss of SOD1 or SOD2 increases
sensitivity to drugs that increase mitochondrial ROS (metadione)
[149,150]. AfSod3, unlike other Mn-Sods, lacks a mitochondrial
signal sequence, suggesting that it is cytoplasmic, and is induced
during the later stages of hyphal growth, however its speciﬁc role
is not known [142]. Mn-Sod4 is constitutively expressed at low lev-
els and is essential- heterozygous diploid SOD4/sod4 strains fail to
produce sod4 spores [142].
Like C. neoformans, mitochondrial activity is important for
Aspergillus thermotolerance and resistance to phagocytic attack:
Sod1 and Sod2 are required for growth above 45 ◦C and are
more sensitive to killing by phagocytes from immunocompetent
mice. However, Sod1-3 are all dispensable for virulence in an
immunocompromised mouse model of infection (OF1). Similarly,
catalase (CatA (expressed in spores), Cat1, Cat2) [151,152], the
stress responsive transcription factor Skn7 [153], and the redox
responsive transcription factor Yap1 are all required for resistance
to exogenous ROS stress [151], but are not required for virulence.
This suggests that, similar to C. neoformans, there is signiﬁcant
redundancy in the fungal oxidative stress response. Consistent with
this, loss of both mycelial catalases (Cat1, Cat2) delays virulence
in a mouse model of aspergillosis [151]. In contrast, mitochondrial
AfCycA is required for growth under hypoxia and for virulence, even
in the presence of a functional alternative oxidase (AfAoxA) [92].
In Aspergillus species, the production of toxins (gliotoxin and
fumagillin) that inhibit the fungicidal activity of neutrophils by
blocking NADPH oxidase formation have a signiﬁcant impact on
survival in the host [154,155]. Inhibiting gliotoxin production
reduced fungal virulence [156]. Neutrophilic NADPH oxidase activ-
ity can also impact fungal programed cell death pathways by
triggering caspase activity. Aspergillus (and other saprophytic fungi)
can express an anti-apoptotic protein, Bir1, that suppresses this
programmed cell death response, enabling growth in the face of
host ROS [157,158].
4. Host oxidative responses in fungal immunity
4.1. Aspergillus speciesIn the CGD host, the absence of functional NADPH oxidase
has an impact on both antifungal effector mechanisms and con-
trol of the inﬂammatory response. Clinical epidemiological data
strongly suggests a direct link between the absence of a functional
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ADPH oxidase complex and infections caused by catalase-positive
icroorganisms. Aspergillus species, which require fungal Nox and
ndogenous ROS to maintain apical growth, are able to breakdown
heir own hydrogen peroxide radicals by catalases. This makes
ungal-derived H2O2 unavailable to phagocytes for conversion
nto more potent fungicidal reactive oxygen intermediates. Animal
tudies focusing on fungal pathogenesis in the CGD host have pre-
ominantly used A. fumigatus as the infective fungal pathogen, and
nly a few have studied the virulence of A. nidulans in CGD mice
159–162]. Nevertheless, in vivo and in vitro studies have reported
naltered virulence of catalase-deﬁcient A. nidulans in p47phox−/−
ice [160,161]. Experimental infections with C. albicans, A. tan-
eri and Neosartorya udagawae have been compared to A. fumigatus
nfections in separate murine studies and likewise suggest roles for
ost NADPH oxidase in infection control [19,163,164].
Aspergillus conidia are mainly killed by non-oxidative intracel-
ular killing mechanisms, either by macrophages or neutrophils
n a phagocytosis-dependent manner. In vitro studies have shown
hat stimulation of human neutrophils (PMN) and peripheral blood
ononuclear cells (PBMC) with either A. fumigatus conidia or
yphae results in increased production of ROS and inhibition of
ermination and fungal killing [165,166]. Surprisingly, the stimu-
ation of ROS showed to be Aspergillus species-speciﬁc: A. nidulans
as shown to be a weak inducer of ROS in both cell types [166]. In
ddition, no defect in inhibiting growth of A. nidulans was observed
n CGD neutrophils [167].
Several studies have investigated the ability of Aspergillus
pecies to modulate host phagocyte ROS and the impact of this
nteraction on fungicidal activity. Akpogheneta et al. [168] evalu-
ted the activity of human PMN  and PBMC against hyphae from
. fumigatus and non-fumigatus Aspergillus species. They concluded
hat non-opsonized hyphae from all species tested suppress the
MN oxidative burst below basal levels, while serum-opsonization
brogated this suppression. However, opsonised A. fumigatus was
ore stimulatory than non-fumigatus Aspergillus species. Similarly,
MN induced less hyphal damage to non-fumigatus Aspergillus
pecies, particularly A. ﬂavus and A. nidulans, than to A. fumiga-
us. [168]. In contrast, we found that non-opsonized hyphae of A.
idulans, being poor ROS inducers, were more effectively damaged
han those of A. fumigatus,  which did induce a robust respira-
ory burst [167]. A more recent study showed unopsonized A.
umigatus hyphae not being killed by healthy human neutrophils
ver a 4 h period. Opsonization of A. fumigatus hyphae with heat-
nactivated serum or immunoglobulin-G preparations resulted in
ffective hyphal killing [168].
The exact role of NADPH oxidase activity in macrophages with
espect to fungicidal properties is less clear, and studies have
roduced conﬂicting results. Experimental studies with alveolar
acrophages (AM) from gp91phox−/− mice showed phagocytosis
nd killing rates of A. fumigatus and A. nidulans conidia comparable
o AM from normal mice [159,167,169,170]. In contrast, AM from
47phox−/− mice were unable to kill A. fumigatus conidia [171,172].
urthermore, healthy murine AM pre-treated with inhibitors of
ADPH oxidase were not able to kill A. fumigatus conidia [171].
ndirect evidence of NADPH-independent resistance in alveolar
acrophages was  found by Shibuya et al., who showed that killing
f catA conidia by alveolar macrophages and conidial virulence
n an animal model were similar to those with wild-type conidia
173].
Microarray data of murine C57BL/6 and gp91phox−/− AM
xposed to A. fumigatus conidia in vivo showed that the most
arked early transcriptional changes did not indicate obvious
ADPH oxidase involvement but instead implicated genes involved
n PMN  recruitment [170]. An examination of invasive pulmonary
spergilosis in an experimental murine model showed that early
MN recruitment is crucial in preventing hyphal proliferation andvelopmental Biology 89 (2019) 34–46
tissue invasion early after infection [169]. Neutrophil recruitment
was slower in gp91phox−/− mice, resulting in increased germination
despite the formation of extensive neutrophilic aggregates in the
lungs at later time points. ROS seem to act as chemo-attractants
early in the infection, but are also involved in the inactivation of
chemotactic molecules, downregulation of IL-8 and clearance of
neutrophils, once sufﬁcient neutrophils have arrived at the site of
infection [174,175].
It is clear that the almost exclusive contribution of NADPH oxi-
dase to microbial killing is a justiﬁed subject of debate, and recent
studies have indicated a critical role of the NADPH oxidase as reg-
ulator of immune homeostasis at multiple levels [17]. We  have
shown that the absence of the respiratory burst is associated with
dysregulated inﬂammation, characterised by uncontrolled IL-1
release in the CGD host, and further contributes to the pathogenesis
of Invasive Aspergillosis (IA) in CGD patients [52,176]. Exagger-
ated IL-1 production has been demonstrated in CGD murine
models of sterile inﬂammation and is associated with excessive
and prolonged inﬂammation and signiﬁcant host damage [177].
Aspergillus provides a potent stimulus for IL-1 production in
CGD, with X-linked CGD mice exhibiting a 5-fold increase in pul-
monary IL-1 mRNA expression compared with wild-type mice
following respiratory challenge with A. fumigatus [159]. The role of
ROS as mediators/regulators in inﬂammation has also been under-
scored by van de Veerdonk et al. [178]. They showed that ROS
appear to dampen inﬂammasome activation. As a consequence, the
absence of ROS in CGD monocytes may  partly explain the inﬂam-
matory complications seen in CGD patients. A recent study by Segal
et al. [179] supports the occurrence of NADPH oxidase-dependent,
redox-mediated signalling which is critical for termination of lung
inﬂammation. By challenging NADPH oxidase-deﬁcient p47phox−/−
mice and gp91phox-deﬁcient mice with intratracheal zymosan, they
showed that NADPH oxidase limits lung inﬂammation by atten-
uating the proinﬂammatory transcription factor NF-kB and by
activating Nrf2, a key redox-sensitive anti-inﬂammatory regulatory
transcription factor.
Studies in mice have shown an important role of NADPH oxi-
dase in IL-17 regulation. Overproduction of IL-17 was  observed
in CGD mice and has been linked with defective l-tryptophan
metabolism due to the ﬁnding that ROS are crucial for indolamine-
2,3-dioxygenase activity, the enzyme responsible for conversion
of l-tryptophan to l-kynurenine [180]. However, in humans with
CGD, tryptophan metabolism has been shown to be intact, indi-
cating that the mechanism of fungal susceptibility is different in
humans and in mice [181–183]. Although it seems that an efﬁcient
anti-Aspergillus defence relies more on a Th1 immune response
[184], the absence of an adequate IL-17 response, as observed in
our study [183], might contribute in the CGD host to the inability
to clear fungal infections.
Using a transgenic zebraﬁsh line expressing the dominant neg-
ative Rac2D57N mutation in neutrophils, Knox et al. were able to
show its importance in antifungal immunity [185]. Rac2 plays a
role in neutrophil migration and the generation of reactive oxy-
gen species forming a complex with the NADPH oxidase. Zebraﬁsh
larvae with this mutation were highly susceptible to A. fumigatus
infection with a mortality of 50% by day 7, while survival was 100%
in wild-type larvae. Only 2 cases of primary phagocytic immunod-
eﬁciency caused by Rac2 mutation have been reported in humans
[53,186–188].
MPO-deﬁcient mice are more susceptible to the develop-
ment of pulmonary infection following the intranasal instillation
of A. fumigatus [189]. The killing of Aspergillus hyphae by
MPO-deﬁcient human neutrophils is defective; however, the
neutrophil-mediated inhibition of Aspergillus conidia germination
has shown to be normal [190]. This may  explain why MPO-
deﬁcient patients are not prone to develop Aspergillus infections,
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nd those infections have not been reported in MPO  deﬁciency
191].
Resting and swollen conidia of A. fumigatus are relatively resis-
ant to peroxynitrite in vitro and only a moderate fungistatic effect
as observed [192].
.2. Candida species
One of the earliest studies reporting a role for oxidative
esponses in an effective immune response against C. albicans was
erformed by Lehrer in 1970 [193]. Using isolated neutrophils from
 healthy controls, 1 MPO-deﬁcient patient and 2 children with
GD, he showed that both myeloperoxidase and hydrogen perox-
de are required for candidacidal activity. However, MPO-deﬁcient
eutrophils cells exerted a demonstrable candidastatic effect, in
ontrast to CGD neutrophils.
In vitro, both yeast and hyphal forms of C. albicans can trig-
er ROS production in bone marrow-derived macrophages as well
s myeloid dendritic cells, with a ﬁve times higher oxidative
urst in murine dendritic cells compared to bone marrow-derived
acrophages [194]. Expanding on the in vitro data, the ﬁrst
n vivo evidence that the phagocyte NADPH oxidase regulates ﬁl-
mentation of C. albicans within the intact host, results from an
xperimental zebraﬁsh model. An intact NADPH oxidase proved
o be crucial to limit fungal proliferations and limiting ﬁlamen-
ous growth after zebraﬁsh larvae were injected with C. albicans
east cells into the hindbrain [120]. That NADPH oxidase has other
unctions than antifungal killing per se during invasive candidiasis,
s has been nicely shown in following studies performed by the
ame group. They showed a mechanistic role of NADPH oxidase in
romoting neutrophil and macrophage chemotaxis and intracellu-
ar containment of C. albicans to limit ﬁlamentous growth [195].
emarkably however, if C. albicans cells were blocked in the yeast
hase, NADPH oxidase activity was no longer required for effec-
ive fungal containment. In addition, their results suggest a role for
on-phagocyte-expressed DUOX (in epithelial cells) in promoting
fﬁcient chemotaxis of phagocytes to the site of infection [195].
The role of NO− in macrophage candidacidal activity has been
ell-established, although NO− itself is not directly candidacidal
or C. albicans [196–199]. Peroxynitrite (ONOO−) is candidacidal
n vitro and has been shown to be responsible for the candidaci-
al activity of NO−-producing macrophages [199]. Mice deﬁcient
n both iNOS and NADPH oxidase showed increased susceptibility
o invasive candidiasis [200]. However, the data showed that this
as unrelated to decreased fungal killing but due to an excessive
nﬂammatory response.
Neutrophils use both oxidative and non-oxidative effector
echanisms to kill Candida spp. [201]. Although both mouse and
uman granulocytes that are deﬁcient in either NADPH oxidase or
PO  are incapable of efﬁcient Candida killing in vitro [193,202].
n vitro studies have shown that MPO-deﬁcient neutrophils exhibit
 defect in candidacidal activity. For example, MPO-deﬁcient leuko-
ytes kill phagocytosed C. albicans much more slowly compared
o normal leukocytes [202,203]. In addition, MPO-deﬁcient mice
ere shown to be increased susceptible to intratracheal C. albicans
nfection [204]. In a study comparing the susceptibility to fungal
nfection with WT,  MPO-deﬁcient, and CGD mice, it was  concluded
hat when the fungal load is low, ROS formed by the NADPH oxidase
f neutrophils are adequate to control infection in the absence of
PO. But at high fungal load, products of the respiratory burst and
PO  are needed [19,205].
Similar survival of wild-type and MPO-deﬁcient zebraﬁsh wasbserved after C. albicans infection [206], being somehow in con-
rast with the previous ﬁndings obtained in a murine model
f MPO-deﬁciency. However, a signiﬁcant higher fungal load
as found during the early phase of infection in the MPO-velopmental Biology 89 (2019) 34–46 41
deﬁcient compared to wild-type zebraﬁsh. Neutrophil migration
was not affected in the MPO-deﬁcient zebraﬁsh. Remarkably, MPO-
deﬁcient zebraﬁsh showed an increased inﬂammatory response
characterised by an increased number of neutrophils at the site of
infection and gene expression of IL-1 and IL-8, at later time points
after infection. In addition, basal gene expression of IL-1 and IL-8
was signiﬁcantly elevated in MPO-deﬁcient zebraﬁsh, comparable
to observation in NADPH oxidase deﬁcient patients [183].
More recent studies have reported distinct and indepen-
dent mechanisms of human neutrophils to kill C. albicans [190].
Unopsonized C. albicans yeasts are killed by non-oxidative mech-
anisms depending on complement receptor 3 (CR3) signalling via
Syk, phosphatidylinositol-3-kinase (PI3K) and caspase recruitment
domain-containing protein 9 (CARD9). Phagolysosomal killing of
serum opsonized C. albicans yeasts is dependent on Fcγ receptors,
protein kinase C (PKC), Syk and ROS production by NADPH oxi-
dase [207]. Using neutrophils from patients with inborn errors of
neutrophil function (e.g. Dectin-1 deﬁcient, CARD-9 deﬁcient and
CGD patients) those differential mechanisms were elegantly shown
[207].
NADPH oxidase deﬁciency in patients with chronic granuloma-
tous disease is associated with signiﬁcantly increased susceptibility
to invasive mould infection, but it has only little effect on sus-
ceptibility to Candida infection [4]. This suggests that alternative
mechanisms in vivo can compensate for a defect in NADPH
oxidase-dependent killing mechanisms. Similarly, MPO  deﬁciency
in humans does not predispose to Candida infection, unless there
are concomitant risk factors (such as diabetes) [208].
4.3. Cryptococcus species
The very ﬁrst study demonstrating a role for oxidative killing
mechanisms in the resistance to cryptococcosis was  made by Dia-
mond et al in 1972 [209]. By inhibiting MPO  activity in neutrophils
from healthy donors and using neutrophils from CGD patients,
defective killing of C. neoformans was observed [209,210]. By neu-
tralizing speciﬁc ROI and using a C. neoformans isolate impaired in
mannitol production, it was  shown that OH− and HOCl are critical
anti-cryptococcal effector molecules [211].
The role of MPO  in an effective immune response against
cryptococci has been shown in experimental murine models.
MPO-deﬁcient mice are more susceptible to the development of
pulmonary infection following the intranasal instillation of Cryp-
tococcus neoformans [212]. Higher fungal burdens were observed
in the lung and spleen, but not in the bloodstream of the MPO-
deﬁcient mice. Whereas cryptococci were hardly recovered from
brain tissue in wild-type mice, signiﬁcant fungal burden were found
in MPO−/− mice on days 34 and 60 post-infection as well has
higher IL-1 release [212]. Granulocyte colony-stimulating factor
(G-CSF) treated neutrophils from HIV-infected patients showed an
enhanced killing of C. neoformans isolates closely related to an aug-
mented ROS production [213,214].
More recently, Davis et al. showed that neutrophils with a muta-
tion in Rac2 (component of the NADPH oxidase complex) were less
able to control fungal burden in a zebraﬁsh larvae model of inva-
sive cryptococcosis [215]. This effect was most pronounced after
infection with the yeast form, supporting a protective effect of
neutrophils late in the infection.
4.4. Pneumocystis jiroveci
Three case reports have been published in the English literature
describing the occurrence of Pneumocystis jiroveci pneumonia (PCP)
in 3 patients with CGD [216–218]. Although this may suggest that a
functional NADPH oxidase is required in the host response against
PCP, in more recent epidemiological studies, PCP is not observed
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s a signiﬁcant infectious complication in patients with CGD [219].
f a defective NADPH oxidase leads to other immunological con-
equences, speciﬁcally to T-cell function and thereby increasing
he risk for PCP, is not well studied. Reactive oxygen species do
ave an impact on several signalling pathways in T-lymphocytes,
ncluding redox-sensitive proteins, transcription factors and Ca2+
hannels [220,221]. Two separate studies have shown that patients
ith CGD have diminished T-cell numbers compared to healthy
ontrols [222,223]. Lower CD3+ T-cell counts were associated with
he development of fungal disease, but differences didn’t reach sta-
istical signiﬁcance [222]. T-lymphocytes do express a gp91phox-
nd p47phox-dependent NADPH oxidase and contributes to the sus-
ained production of H2O2 after TCR engagement [224]. Studies
erformed with T-cells derived from gp91phox−/− and p47phox−/−
ice and humans (CGD patients) demonstrate a defect in TCR-
nduced production of hydrogen peroxide [224]. Nevertheless, the
mportance of the NADPH oxidase in T-lymphocytes in antifungal
mmunity remains to be clariﬁed.
. Concluding remarks
Here we have discussed the inﬂuence of host and fungal-derived
OS and RNS on fungal infection biology with a focus on three
ajor human fungal pathogens, A. fumigatus, C. neoformans, and
. albicans. Throughout, an emerging theme is that ROS production,
egulation, and response are a central axis of the host-pathogen
nteraction. Both host and fungi produce ROS, use conserved mech-
nisms to detoxify ROS, and leverage ROS in their local environment
o mediate defence mechanisms. ROS production and detoxiﬁca-
ion also intersect with host nutritional immunity, and in at least
ne instance, host ROS stimulate altered amino acid biosynthesis in
 fungus. The signiﬁcance of ROS for fungal killing is clear, however
here are several examples of host ROS either not being required
o control the growth of fungi (A. nidulans in CGD) or contributing
o fungal pathogenesis by providing signals for the yeast-to-hyphal
witch (C. albicans hyperpolarised buds). A greater understanding
f both the dynamics of oxidative attack and the consequences
f defective phagocyte ROS and RNS production on fungal growth
nd morphology in vivo could have an impact on the treatment of
atients with invasive fungal infections.
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